KRAS wild-type status is associated with survival benefit in cetuximab treated metastatic colorectal cancer, and an even greater benefit is seen in patients with early radiological response. Annals of Oncology
Metabolic syndrome does not have a reliable biomarker that captures its various features. Could high-sensitive C-reactive protein, adiponectin, or ratio of adiponectin or its oligomers predict MetS? American Journal of Clinical Pathology
A test that measures interferon-gamma release in response to bacterial antigens is more accurate than skin tests in detecting latent tuberculosis infection in patients with rheumatoid arthritis, new research shows. However, a second study found that this type of test yielded indeterminate results. Reuters Health Information
U.S. researchers have identified a number of genetic variants that may help determine which smoking cessation treatment will work best in an individual smoker. Reuters Health Information
HER-2/neu status in 100 consecutive ductal breast carcinomas using the FDA and American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) scoring systems were evaluated. American Journal of Clinical Pathology
A 38-year-old female presented with severe headache, nausea, vomiting, and palpitations. Learn why her diagnosis was cardiogenic shock. Laboratory Medicine
A nicotinamide N-methyltransferase (NNMT) polymorphism in association with periconception exposure to medicines and low dietary nicotinamide intake markedly increases the risk for congenital heart defects, according to a report in the June issue of the European Heart Journal. Reuters Health Information